Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations-Reference-Cited by-同舟云学术

Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations

Published:2018-04-17 Issue:29 Volume:9 Page:20928-20940
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Greil Richard¹²³,Pleyer Lisa¹²³,Jansko Bettina¹,Feierabend Carmen¹,Rettenbacher Lukas⁴,Stiefel Olga⁵,Rass Christoph¹,Morre Patrick¹,Neureiter Daniel³⁶,Greil-Ressler Sigrun¹

Affiliation:

1. IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Disease and Rheumatology, Oncologic Center, Paracelsus Medical University, A-5020 Salzburg, Austria

2. Salzburg Cancer Research Institute, A-5020 Salzburg, Austria

3. Cancer Cluster Salzburg, A-5020 Salzburg, Austria

4. Department of Nuclear Medicine, Paracelsus Medical University, A-5020 Salzburg, Austria

5. Ordensklinikum Linz, A-4010 Linz, Austria

6. Institute of Pathology, Paracelsus Medical University, A-5020 Salzburg, Austria

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next Generation Sequencing Analysis of Fibrin-associated Large B-cell Lymphoma Reveals Pathogenic Single Nucleotide Variants;Anticancer Research;2024-02

2. Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma;Pathology and Oncology Research;2023-03-17

3. JAK/STAT blockade reverses the malignant phenotype of Hodgkin and Reed-Sternberg cells;Blood Advances;2022-12-02

4. KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders;Cancers;2022-01-28

5. Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30‐positive aggressive lymphomas;European Journal of Haematology;2020-01-10